IIL Shares A Good Buy
Intravenous Infusions Limited (IIL) managed to churn out a better performance for the year 2016 compared to prior year before listing on the Ghana Alternative Market (GAX). Revenue of the company grew by 40.7% y/y; from GHS 7,529,883 in 2015 to GHS 10,596,009 in 2016. Revenue growth was largely driven by a 7.5% increase in … Read more